Literature DB >> 1433374

Oral etoposide in treatment of advanced refractory sarcomas.

C E Kampe, S Lowenbraun, J Foster, G Rosen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1433374     DOI： 10.1093/jnci/84.23.1836

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Phase IV trial of daily oral etoposide in the treatment of advanced soft-tissue sarcoma.

Authors:  J D Licht; R Mazanet; P J Loehrer; R Gonin; K H Antman
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma.

Authors:  H J Keizer; D Crowther; O S Nielsen; A T Oosterom; J H Muguiro; C V Pottelberghe; R Somers; T Tursz
Journal:  Sarcoma       Date:  1997

3.  A Phase I/II Study of a 72-h Continuous Infusion of Etoposide in Advanced Soft Tissue Sarcoma.

Authors:  C R Crawley; I R Judson; M Verrill; C Hill; F I Raynaud
Journal:  Sarcoma       Date:  1997
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.